Patients with systemic lupus erythematosus (SLE) who develop pneumonia have a high risk of adverse prognosis, according to a…
Articles by Jose Marques Lopes, PhD
A series of recently identified small molecules targeting a protein called NR2F6 could lead to new treatments for autoimmune diseases…
Virgin olive oil, especially its phenol components, showed anti-inflammatory properties in mice with systemic lupus erythematosus (SLE) and in human…
At the time of diagnosis, systemic lupus erythematosus (SLE) patients already show signs of heart impairment, even before any symptoms of…
Interferon-kappa (IFN-κ), an immune response regulator, is a key mediator of skin lesions and UV light sensitivity in cutaneous lupus…
The Lupus Research Alliance awarded Novel Research Grants to two University of Alabama at Birmingham (UAB) researchers…
DxTerity Diagnostics’ LIFT study supports the use of social media to rapidly enroll lupus patients for clinical…
Early treatment to reduce disease activity and prevent irreversible organ damage in pediatric systemic lupus erythematosus (pSLE) patients should…
A type of immune cell that protects against viruses and cancer may worsen systemic lupus erythematosus (SLE) and trigger…
Systemic lupus erythematosus (SLE) is a major cause of death in young women that goes largely unrecognized due to its…